Aria Biosystems

company

About

Aria Biosystems, located in Menlo Park, Calif., is developing and commercializing tools to make the detection and analysis of biomolecules.

Details

Last Funding Type
Series A
Last Funding Money Raised
$5.50M
Industries
Analytics,Biotechnology,Innovation Management,Medical
Founded date
Jan 1, 2004
Operating Status
Active

Aria Biosystems is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics and concentration.

Aria utilizes proprietary bio-layer interferometry (BLI) that enables self-calibration and measurement of molecular interactions using simple-to-use and inexpensive instrumentation. The entire analysis can be completed within minutes and does not require labeling of either probe or target. Aria's analytical capabilities provide greater value in applications where existing methods such as HPLC, ELISA and surface plasmon resonance (SPR) have limitations in throughput, performance and cost.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.50M
Aria Biosystems has raised a total of $5.50M in funding over 2 rounds. Their latest funding was raised on Jun 15, 2004 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 15, 2004 Series A $5.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aria Biosystems is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series A